Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

NewAmsterdam Pharma Co N.V (NAMS) Return on Capital Employed: 2024-2025

Historic Return on Capital Employed for NewAmsterdam Pharma Co N.V (NAMS) over the last 2 years, with Sep 2025 value amounting to -0.27%.

  • NewAmsterdam Pharma Co N.V's Return on Capital Employed rose 19.00% to -0.27% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.27%, marking a year-over-year increase of 19.00%. This contributed to the annual value of -0.35% for FY2024, which is 15.00% up from last year.
  • As of Q3 2025, NewAmsterdam Pharma Co N.V's Return on Capital Employed stood at -0.27%, which was down 23.41% from -0.22% recorded in Q2 2025.
  • Over the past 5 years, NewAmsterdam Pharma Co N.V's Return on Capital Employed peaked at -0.22% during Q2 2025, and registered a low of -0.55% during Q1 2024.
  • Its 2-year average for Return on Capital Employed is -0.37%, with a median of -0.32% in 2024.
  • Data for NewAmsterdam Pharma Co N.V's Return on Capital Employed shows a peak YoY skyrocketed of 32bps (in 2025) over the last 5 years.
  • Over the past 2 years, NewAmsterdam Pharma Co N.V's Return on Capital Employed (Quarterly) stood at -0.32% in 2024, then increased by 19bps to -0.27% in 2025.
  • Its last three reported values are -0.27% in Q3 2025, -0.22% for Q2 2025, and -0.24% during Q1 2025.